Sosei Collaborates With GSK On Immune Disorders Of Digestive System; Eligible To Receive Up $481 Mln
(RTTNews) - Japan's Sosei Group Corp said that it has reached a global collaboration and license agreement with GlaxoSmithKline Plc (GSK.L, GSK) targeting immune disorders of the digestive system in a ...
GSK is paying $70 million to plug into Tempus’ AI-enabled patient data platform with the aim of improving its clinical trial design, speeding up enrollment and identifying new drug targets. Tempus’ ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a multi-year collaboration with GSK on the development of a next-generation equipment design, building upon Pfizer’s existing portable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback